Cargando…
Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort
The efficacy of pharmaceutical cognitive enhancers in everyday complex tasks remains to be established. Using the knapsack optimization problem as a stylized representation of difficulty in tasks encountered in daily life, we discover that methylphenidate, dextroamphetamine, and modafinil cause knap...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266726/ https://www.ncbi.nlm.nih.gov/pubmed/37315143 http://dx.doi.org/10.1126/sciadv.add4165 |
_version_ | 1785058797577830400 |
---|---|
author | Bowman, Elizabeth Coghill, David Murawski, Carsten Bossaerts, Peter |
author_facet | Bowman, Elizabeth Coghill, David Murawski, Carsten Bossaerts, Peter |
author_sort | Bowman, Elizabeth |
collection | PubMed |
description | The efficacy of pharmaceutical cognitive enhancers in everyday complex tasks remains to be established. Using the knapsack optimization problem as a stylized representation of difficulty in tasks encountered in daily life, we discover that methylphenidate, dextroamphetamine, and modafinil cause knapsack value attained in the task to diminish significantly compared to placebo, even if the chance of finding the optimal solution (~50%) is not reduced significantly. Effort (decision time and number of steps taken to find a solution) increases significantly, but productivity (quality of effort) decreases significantly. At the same time, productivity differences across participants decrease, even reverse, to the extent that above-average performers end up below average and vice versa. The latter can be attributed to increased randomness of solution strategies. Our findings suggest that “smart drugs” increase motivation, but a reduction in quality of effort, crucial to solve complex problems, annuls this effect. |
format | Online Article Text |
id | pubmed-10266726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102667262023-06-15 Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort Bowman, Elizabeth Coghill, David Murawski, Carsten Bossaerts, Peter Sci Adv Neuroscience The efficacy of pharmaceutical cognitive enhancers in everyday complex tasks remains to be established. Using the knapsack optimization problem as a stylized representation of difficulty in tasks encountered in daily life, we discover that methylphenidate, dextroamphetamine, and modafinil cause knapsack value attained in the task to diminish significantly compared to placebo, even if the chance of finding the optimal solution (~50%) is not reduced significantly. Effort (decision time and number of steps taken to find a solution) increases significantly, but productivity (quality of effort) decreases significantly. At the same time, productivity differences across participants decrease, even reverse, to the extent that above-average performers end up below average and vice versa. The latter can be attributed to increased randomness of solution strategies. Our findings suggest that “smart drugs” increase motivation, but a reduction in quality of effort, crucial to solve complex problems, annuls this effect. American Association for the Advancement of Science 2023-06-14 /pmc/articles/PMC10266726/ /pubmed/37315143 http://dx.doi.org/10.1126/sciadv.add4165 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Neuroscience Bowman, Elizabeth Coghill, David Murawski, Carsten Bossaerts, Peter Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort |
title | Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort |
title_full | Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort |
title_fullStr | Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort |
title_full_unstemmed | Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort |
title_short | Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort |
title_sort | not so smart? “smart” drugs increase the level but decrease the quality of cognitive effort |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266726/ https://www.ncbi.nlm.nih.gov/pubmed/37315143 http://dx.doi.org/10.1126/sciadv.add4165 |
work_keys_str_mv | AT bowmanelizabeth notsosmartsmartdrugsincreasethelevelbutdecreasethequalityofcognitiveeffort AT coghilldavid notsosmartsmartdrugsincreasethelevelbutdecreasethequalityofcognitiveeffort AT murawskicarsten notsosmartsmartdrugsincreasethelevelbutdecreasethequalityofcognitiveeffort AT bossaertspeter notsosmartsmartdrugsincreasethelevelbutdecreasethequalityofcognitiveeffort |